Attitudes to aspirin use in diabetes in clinical practice: a survey of health care professionals from primary and secondary care settings in the UK

摘要

Aspirin has been the subject of research and debate throughout its long history. Although aspirin has been unequivocally advocated for the prevention of ischaemic heart disease, its use in diabetes is not fully clarified. Given the varied aetio-logical elements in the development of type 2 diabetes and ensuing cardiovascular risk in all forms of diabetes, the role and dose of aspirin in this high-risk population may need to be redefined.The role of aspirin in the secondary prevention of cardiovascular disease is unequivocal with a significant reduction in secondary events by an impressive 22% in all trials.1'2 The results were similar in subjects with diabetes.